Addresses whether a group purchasing organization based prescription-drug program operated for the benefit of a group of non-profit schools, colleges, and universities would fall within the Non-Profit Institutions Act (NPIA) exemption to the Robinson-Patman Act
FTC staff issue advisory opinions to help clarify FTC rules and decisions, often in response to requests from businesses and industry groups. To find a specific opinion, use the filters on this page.
Health Care Antitrust Issues
Re: Follow-Up to February 9, 2002 MedSouth, Inc. Staff Advisory Opinion
re: Proposed settlement of infringement litigation with Teva Pharmaceuticals involving sharing of the exclusivity period for the drug Paraplatin.
re: Transfer of pharmaceuticals at cost by non-profit hospital to patients of non-profit Free Clinic